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assays were, respectively: rutin (9.62 ± 0.28 and 8.1 ± 0.54), EE (70.97 ± 1.53 and 55.44 
± 2.8), HF (213.38 ± 2.94 and 164.73 ± 2.34 ), OF (83.43 ± 2.94 and 109.42 ± 0.51 ), AF 
(24.99 ± 0.16 and 24.37 ± 2.18) and BF (52.28 ± 3.07 and 57.33 ± 1.92). In the ~-caro­
tene bleaching assay, the percentage inhibition (%1) was: EE = 51.02±1.92; HF = 82.17 
± 1.62; OF= 71.21 ± 1.07; AF = 73.65 ± 0.75 and BF = 42.97 ± 2.58. EE and fractions 
showed higher %1 than rutin (5.82 ± 0.81 ), whi le EE and BF produced lower values than 
quercetin (64.08 ± 2.13). The bioautography data revealed that the antioxidant effect is 
due the presence of phenolic compounds, particularly flavonoids. These results suggest 
that G. hirsutum is an important and promising source of bioactive molecules with anti-
oxidant action. 
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In the last two decades, an increasing incidence of opportunistic fungal infections has 
been observed, not only at hospital level but also in the community. Candida albicans 
was identified as the main responsible agent for those infections, but other non-Candi-
da albicans Candida (NCAC) species have also been associated with this complicated 
medical condition [1 ]. Furthermore, higher rates of fungal resistance to the current drugs 
have been observed and are still growing, making the discovery of new active antifungal 
substances very urgent. Medicinal plants can be explored for that purpose. Glycyrrhiza 
glabra L. is commonly used in folk medicine due to its antimicrobial and antiviral activi-
ties, as well as for a wide variety of dermal affections [2]. Some reports have described 
the antimicrobial potential of licorice (G. glabra roots), namely aqueous extracts [e.g ., 3]. 
Herein. the antifungal potential of the hydroalcoholic extract prepared from rhizomes and 
roots of G. glabra, was evaluated against 19 Candida strains. using the disc diffusion 
halo assay. The licorice extract was effective against all the tested C. albicans, C. gla-
brata, C. parapsilosis and C. tropicalis strains. lt is very interesting to highlight the broad 
spectrum of activity of this extract, for which were observed similar results into different 
strains of the same species and even between different species. The results for the 
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-inhibitory zones, at the tested concentration (50 mg/mL), after 24h, were 1.0-1.2 cm for 
C. albicans and C. parapsilosis, 1.0-1.3 cm for C. tropicalis and 1.2 cm for C. glabrata, 
maintaining the potential at 48h and even at 72h. This study demonstrates that G. gla-
bra hydroalcoholic extract probably exerts mainly fungicidal and not so much fung istatic 
effects, and it could find applications in antifungal therapy. Nevertheless, further studies 
will be performed in order to characterize the extract, namely on phenolic composition, 
and to elucidate its mechanism of action. 
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Cassia fistula L. is widely used in Thai folklore medicines for its various medicinal proper-
ties. The pulp of ripe pods possesses a mild, pleasant purgative action due to anthraqui-
none glycosides, the active laxative components. Although the pod has long been used 
for its laxative effect, no study has been performed to clinically prove its in vivo action. 
The objective of this randomized crossover, double blind, controlled trial was to compare 
the laxative effectiveness of C. fistula pod pulp extract to the popular laxative drug from 
C. angustifolia in patients with constipation. Thirty six Thai participants diagnosed with 
constipation based on Rome Ill Criteria [1] were randomized into 2 groups, the treatment 
group (n = 17) and the standard group (n = 19). The first group was assigned to have 
five days of treatment with the control drug, Cassia angustifolia commercial capsules, 
stop taking the drug for 5 days, and then take the sample drug of C. fistula pod pulp 
extract capsules for five more days. The second group received the same treatment but 
in a reversed order. Each patient received 8 capsules of drug before bed time every day 
and was asked to fill in a daily stool chart. Main outcome measurements included stool 
frequency and quantity, consistency, ease of evacuation, and adverse effects. In terms 
of laxative effectiveness of the two types of drugs, there was no significant difference 
between the two groups (p > 0.05). Taken into consideration of lower anthraquinone 
content (0.96 mg calculated as rehin) in C. fistula pod pulp than in C. angustifolia product 
(15 mg calculated as sennoside B), C. fistula should provide more laxative effectiveness 
than C. angustifolia if the doses of both drugs contained the equal amount of anthraqui-
none glycosides. Ethnologically, C. fistula pod has long been used as a laxative due to its 
safety and inexpensiveness, and therefore should be promoted as a commercial laxative 
drug just like senna. 
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